Across TCGA pan-cancer cohorts, LINC00710 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated LINC00710 data layer compared with 1 for mutation status.
The strongest signal is observed in adrenocortical carcinoma (ACC), where higher LINC00710 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC00710 expression acts as an unfavorable survival marker, although some lineages such as BRCA and LUAD show a favorable association.
ACC, BRCA, and LUSC are the cancer types where LINC00710 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.